Active Clinical Trials

Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.

Showing 164 results
  • Sort by
  • Study title
  • Condition
  • Phase
  • Location
Study title Condition Phase Location NCT ID

Implementation Study to Describe and Compare Retention Rate and Adherence to Adjuvant Therapy With Ribociclib With and Without Usage of Mobile Application in Patients With HR+ HER2-negative Stage II and III Breast Cancer in Real-world Practice

 		Breast Cancer Russia NCT06905301

Real-world Secukinumab Outcomes in Canadian HS Patients

 		Hidradenitis Suppurativa Canada NCT07282015

Study to Evaluate the Impact of a Targeted Lipid Optimization Program on LDL-C Control in At-risk Adult Patients With Dyslipidemia

 		Atherosclerotic Cardiovascular Disease Phase4 United Arab Emirates NCT07034690

Study of Ianalumab in Adults With Primary Immune Thrombocytopenia (ITP) and Warm-antibody Autoimmune Hemolytic Anemia (wAIHA) Who Have Previously Benefited From Ianalumab

 		Primary Immune Thrombocytopenia, Warm Autoimmune Hemolytic Anemia Phase2 Belgium
China
Czechia
Italy
Malaysia
Singapore
Turkey (Türkiye)
United Kingdom
View all
 NCT07039422

A Phase I Study of JSB462 (Luxdegalutamide) in Japanese Patients With Metastatic Prostate Cancer

 		Metastatic Prostate Cancer (mCRPC) Phase1 Japan NCT07174063

Ilaris NIS in Korea

 		Hereditary Periodic Fever Syndromes, Cryopyrin-associated Periodic Syndromes (CAPS), Colchicine Resistance Familial Mediterranean Fever (crFMF), TNF Receptor Associated Periodic Syndrome (TRAPS), Hyper-IgD Syndrome / Mevalonate Kinase Deficiency (HIDS/MKD), Systemic Juvenile Idiopathic Arthritis (sJIA) South Korea NCT06838143

Short-term Treatment Satisfaction in Hidradenitis Suppurativa Patients Initiated on Cosentyx in Routine Clinical Practice in Saudi Arabia

 		Hidradenitis Suppurativa (HS) Saudi Arabia NCT06785779

Fabhalta Capsules Specified Drug-use Survey

 		C3 Glomerulopathy Japan NCT07156149

Real-world Evaluation of Patient Outcomes and Experiences With Ribociclib Early Adopters.

 		Breast Cancer United Kingdom NCT07243002

Leqvio rPMS (Regulatory Post-Marketing Surveillance in Korea)

 		Primary Hypercholesterolemia or Mixed Dyslipidemia South Korea NCT06770543